基本信息
views: 42
Career Trajectory
Bio
The Beg laboratory is interested in developing new strategies aimed at modulating the tumor microenvironment to increase tumor immunogenicity and response to therapeutics. Through both laboratory and clinical trial studies, ongoing projects aim to modulate activity of epigenetic and cytokine pathways to enhance immunological control of lung cancer. The Beg laboratory is also developing novel oncolytic virus strategies to generate potent anti-tumor T cell responses that can turn immune “cold” to “hot” tumors capable of responding to checkpoint inhibitors and other immunotherapeutics.
Research Interests
Papers共 139 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Mohammed L. Ibrahim, Hong Zheng,Margaret L. Barlow, Yousuf Latif,Zhihua Chen,Xiaoqing Yu,Amer A. Beg
JOURNAL OF IMMUNOLOGYno. 4 (2024): 737-747
Cancer Researchno. 6_Supplement (2024): 6655-6655
J. Guo, D. Kim, J. Gao,C. Kurtyka,H. Chen, C. Yu, D. Wu, A. Mittal,A. A. Beg,S. P. Chellappan,E. B. Haura,J. Q. Cheng
crossref(2024)
Sandhya Prabhakaran, Taylor M. Bursell,Kimberly Luddy, Julian Pineiro,Rafael Bravo,Jeffrey West, Megan Johnson,Mark Robertson-Tessi,Amer A. Beg,Jhanelle E. Gray,Scott Antonia,Robert A. Gatenby,
CANCER RESEARCHno. 3 (2024)
J. Guo,D. Kim, J. Gao,C. Kurtyka,H. Chen, C. Yu,D. Wu, A. Mittal,A. A. Beg,S. P. Chellappan,E. B. Haura,J. Q. Cheng
crossref(2023)
Journal of Clinical Oncologyno. 16_suppl (2023): 9125-9125
crossref(2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn